| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83701 |
DOTA-ECL1i 7-氨基酸CCR2结合肽[外环1变型(ECL1i)]偶联DOTA大环配体 |
170 |
h |
2024-12-18 |
| 83702 |
MC-EVCit-PAB-MMAE（CAS号：2873452-49-2） |
102 |
WYQ |
2024-12-18 |
| 83703 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
127 |
h |
2024-12-18 |
| 83704 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
119 |
h |
2024-12-18 |
| 83705 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
127 |
h |
2024-12-18 |
| 83706 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
119 |
h |
2024-12-18 |
| 83707 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
110 |
h |
2024-12-18 |
| 83708 |
Ald-CH2-PEG2-CH2CO2 tBu ester，cas:2230956-95-1 |
133 |
zyl |
2024-12-18 |
| 83709 |
cas:796073-55-7，4-Methyl-4-(methyldisulfanyl)pentanoic acid，4-甲基-4-(甲基二硫烷基)戊酸 |
102 |
kx |
2024-12-18 |
| 83710 |
Ad-PG-FA 线性聚缩水甘油修饰叶酸靶向分子 |
131 |
h |
2024-12-18 |
| 83711 |
三嵌段共聚物PCL-PEEGE-PCL |
227 |
h |
2024-12-18 |
| 83712 |
炔基功能化的聚乙二醇(alkynyl-PEG) |
111 |
h |
2024-12-18 |
| 83713 |
cas:784105-33-5，Amino-PEG3-C2-acid，3-[2-[2-(2-氨基乙氧基)乙氧基]乙氧基]丙酸 |
115 |
kx |
2024-12-18 |
| 83714 |
Phthalamidoxy-PEG2-CH2-ald，cas:1415246-44-4 |
109 |
zyl |
2024-12-18 |
| 83715 |
甘草次酸偶联Gd-DOTA(GGD) |
103 |
h |
2024-12-18 |
| 83716 |
Fmoc-NH-PEG6-CH2COOH，cas:437655-96-4 |
94 |
zyl |
2024-12-18 |
| 83717 |
cas:557756-85-1，Fmoc-NH-PEG4-CH2CH2COOH，5,8,11,14-四氧杂-2-氮杂十七烷二酸1-(9H-芴-9-基甲基)酯 |
143 |
kx |
2024-12-18 |
| 83718 |
DOTA-3-酪氨酰基-奥曲肽 DOTA-TATE |
116 |
h |
2024-12-18 |
| 83719 |
DBCO-DOTA-Eu 叠氮功能化修饰OTA-Eu |
243 |
h |
2024-12-18 |
| 83720 |
HO-PEG10-CH2COOtBu |
134 |
zyl |
2024-12-18 |
| 83721 |
cas:1026987-94-9，DUPA(OtBu)-OH |
123 |
kx |
2024-12-18 |
| 83722 |
NOTA/DFO-MAL-Cys-MZHER2 亲和体Cys-MZHER2偶联螯合剂NOTA/DFO-MAL |
136 |
h |
2024-12-18 |
| 83723 |
N-DBCO-N-bis(PEG2-amide-PEG4-Val-Cit-PAB-MMAE) |
133 |
WYQ |
2024-12-18 |
| 83724 |
Propargyl-PEG2-CH2CO2-NHS ester，cas:2244145-13-7 |
125 |
zyl |
2024-12-18 |
| 83725 |
NHS ester-PEG4-Val-Cit-PAB-MMAE，（二苯并环辛炔N-羟基琥珀酰亚胺酯） |
272 |
WYQ |
2024-12-18 |
| 83726 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-1-柰丙氨酸-奥曲肽 DOTA-NOC |
118 |
h |
2024-12-18 |
| 83727 |
CAS号为1350456-56-2的Fmoc-Val-Cit-PAB-MMAE |
117 |
WYQ |
2024-12-18 |
| 83728 |
Azido-PEG3-CH2CO2Me，cas:1253389-31-9 |
115 |
zyl |
2024-12-18 |
| 83729 |
cas:60444-78-2，Ald-Ph-NHS ester，4-甲酰苯甲酸N-琥珀酰亚胺酯 |
216 |
kx |
2024-12-18 |
| 83730 |
荧光染料sulfo-Cy5.5-NHS酯 |
160 |
h |
2024-12-18 |
| 83731 |
DOTA-NVVRQ DOTA-TMTP1 双功能螯合剂DOTA偶联多肽TMTP1(NVVRQ) |
136 |
h |
2024-12-18 |
| 83732 |
CAS号为2353409-69-3的Mal-PEG8-Val-Cit-PAB-MMAE |
238 |
WYQ |
2024-12-18 |
| 83733 |
聚DOTA新型树枝状分子(PDOTA) |
142 |
h |
2024-12-18 |
| 83734 |
Anti-EGFR (cetuximab)-EDC/NHS-methotrexate |
226 |
kx |
2024-12-18 |
| 83735 |
CAS号为646502-53-6的MC-Val-Cit-PAB-MMAE |
188 |
WYQ |
2024-12-18 |
| 83736 |
介孔硅纳米粒子(MSNs) |
265 |
h |
2024-12-18 |
| 83737 |
DO3A-Ether-Rhein 10-{[6-(1,8-二羟基蒽醌-3-甲酰氨基)乙氧基乙基]氨基}羰酰甲基-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸 |
155 |
h |
2024-12-18 |
| 83738 |
MC-Val-Cit-PAB-MMAF（或简写为Vc-MMAF） |
186 |
WYQ |
2024-12-18 |
| 83739 |
Anti-CD33 (h2H12ec)-Mc-VC-SGD-1882， ADC试剂 |
166 |
kx |
2024-12-18 |
| 83740 |
FITC-cNGR 绿色荧光素FITC标记cNGR环状 |
140 |
h |
2024-12-18 |
| 83741 |
Azide-PEG3-Val-Cit-PAB-MMAF，叠氮-三聚乙二醇-Val-Cit-PAB-MMAF |
129 |
WYQ |
2024-12-18 |
| 83742 |
cas:2454675-51-3，t-butyl-C18-D-Glu-OtBu，ADC定制 |
136 |
wyh |
2024-12-18 |
| 83743 |
包裹瑞喹莫德的PS脂质体（PS-R848）,包裹R848的PS仿生脂质体 |
321 |
axc |
2024-12-18 |
| 83744 |
MC-Val-Cit-Doxorubicin（CAS号：159857-70-2） |
142 |
WYQ |
2024-12-18 |
| 83745 |
Anti-CD22 (clone G5/44)-AcBut-CalichDMH，ADC定制 |
148 |
kx |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询